Enara Bio
Emily Xin Chun Tye is a Scientist at Enara Bio since March 2022, specializing in TCR discovery and validation. Prior to this, Emily served as an Associate Scientist and Research Associate at the University of Birmingham from March 2021 to March 2022, where involvement was in the UK COVID Immunology Consortium epitope mapping project. Emily holds a Master of Science in Cancer Immunology and Biotechnology from the University of Nottingham (2019-2020) and a Bachelor of Science in Biotechnology from the University of Nottingham Malaysia (2016-2019).
This person is not in any offices
Enara Bio
Enara Bio’s mission is to shine a light on unconventional targets and develop the next generation of cancer immunotherapies designed to treat a broad patient population. Enara Bio is exploring the hidden depths of cancer and T-cell biology to discover and characterize novel immunotherapy targets, such as MR1-presented ligands and Dark Antigens™, which arise from altered cellular processes in cancer cells.